Rezolute, Inc., a company specializing in treatments for refractory hypoglycemia caused by hyperinsulinism, announced its participation in the Guggenheim Healthcare Innovation Conference (Nov 9-11) and the Jefferies London Healthcare Conference (Nov 16-19). Management will hold one-on-one meetings with investors to discuss their antibody therapy, ersodetug, currently in late-stage development. These events offer investors a chance to learn more about Rezolute's progress and upcoming clinical milestones.
Rezolute's upcoming participation in investor conferences is noted here with Pluang's Health-sector market data as of Nov 02, 2026 19:21 WIB: Out of 150 priced US health stocks, 82 rose and 47 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 11.79 with a 4.99% increase, ALMS (Alumis Inc. Common Stock) at USD 7.04 up 4.45%, and HRTX (Heron Therapeutics Inc) at USD 0.29 rising 4.43%.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
